Similarly, in the heart, enhanced glucose metabolism through cardiac specific activation of Hexokinase 2 attenuated, rather than enhanced, cardiac hypertrophy by increasing pentose pathway flux, thereby increasing NADPH (36). The gene discussed is HK2; the disease is cardiac hypertrophy.